Scarica l'app Stockscreener
5.70
1.38%
-0.08
Dopo l'orario di chiusura:
5.61
-0.09
-1.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Wall Street Zen Upgrades Maravai LifeSciences (NASDAQ:MRVI) to Buy - MarketBeat
Maravai (MRVI) Q2 2026 Earnings Call Transcript - AOL.com
Maravai LifeSciences (MRVI) group reports 4.0M shares, 2.72% beneficial stake - Stock Titan
Dimensional Fund Advisors LP Boosts Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Maravai Q2 2026 slides: margin expansion drives EBITDA guidance raise By Investing.com - Investing.com Nigeria
Maravai LifeSciences (MRVI) Releases Q2 2026 Earnings: Revenue Beats Estimates and Loss Narrows - Quiver Quantitative
Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating - Moomoo
Maravai LifeSciences Holdings, Inc. (MRVI) stock price, news, quote and history - Yahoo Finance Singapore
MRVI Maintains Overweight Rating by Wells Fargo -- Price Target Raised to $6.50 - GuruFocus
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap DownHere's What Happened - MarketBeat
Wells Fargo & Company Issues Positive Forecast for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat
Maravai LifeSciences posts investor presentation on mRNA, gene editing, cell and gene therapy tools platform - Bitget
Earnings call transcript: Maravai LifeSciences beats Q2 2026 estimates, shares fall - Investing.com South Africa
Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Challenges with Biotech Innovation - DirectorsTalk Interviews
MRVI Looks 63.2% Overvalued on GF Value™ - GuruFocus
Is Maravai LifeSciences (MRVI) Overvalued After Q2 Earnings Miss? GF Score: 61/100 - GuruFocus
Maravai LifeSciences Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Maravai LifeSciences Q2 Earnings Call Highlights - finance.yahoo.com
Maravai LifeSciences Holdings Inc (MRVI) (Q2 2026) Earnings Call - GuruFocus
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Inv - The National Law Review
Maravai LifeSciences Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-08-06 - Seeking Alpha
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Maravai LifeSciences Holdings Inc Earnings Call Transcript - GuruFocus
MRVI: Q2 revenue up 9% to $51.4M; EBITDA guidance raised on margin expansion confidence - TradingView
MRVI: Revenue and margins rose sharply in H1 2026, with net loss narrowing and debt refinanced - TradingView
Maravai LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance
Maravai Lifesciences in focus: Can Q1 momentum hold in earnings? - Investing.com
Maravai Lifesciences in focus: Can Q1 momentum hold in earnings? By Investing.com - Investing.com Nigeria
Maravai Lifesciences Holdings Inc (NASDAQ: MRVI) Stock Price, News & Analysis - Kalkine
Maravai Q2 2026 slides: margin surge amid operational turnaround - Investing.com
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - The National Law Review
Lazard Asset Management LLC Sells 170,919 Shares of Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Downgraded by Wall Street Zen to Hold - MarketBeat
Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday - MarketBeat
Maravai LifeSciences Holdings Inc - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Cash Flow - TradingKey
MRVI|Maravai LifeSciences Holdings Inc|Price:6.760|Chg%:-0.290 - TradingKey
TradingKey - TradingKey
MRVI|Maravai LifeSciences Holdings Inc|Price:6.690|Chg%:-0.070 - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Maravai LifeSciences Holdings, Inc. Revenue Breakdown – NASDAQ:MRVI - TradingView
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Maravai LifeSciences(MRVI) Stock Options Chain | Quotes & News - Moomoo
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - The National Law Review
Maravai LifeSciences to announce Q2 results on August 6 - scanx.trade
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 - Business Wire
Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – FWB:MAR - TradingView
MRVI Secures New Patent for RNA Synthesis Technology - GuruFocus
TriLink receives China patent for CleanCap mRNA technology - Investing.com
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology - Yahoo Finance
Brummer Multi Strategy AB Has $2.15 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Maravai Lifesciences Holdings stock hits 52-week high at 7.1 USD - Investing.com Nigeria
Maravai LifeSciences (MRVI) Edges Higher: Testing Key Resistance Amid Modest GainsPullback Trade - dars.gov.et
Maravai LifeSciences (NASDAQ:MRVI) Hits New 1-Year HighTime to Buy? - MarketBeat
Form 4 Maravai Lifesciences Holdings Inc For: 10 July By Investing.com - Investing.com Nigeria
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):